Aignostics combines proprietary access to multimodal clinical datasets, industry-leading AI technologies, and rigorous science to develop best-in-class insights for the next generation of precision medicine. Through collaborations with its biopharma partners, Aignostics supports drug discovery, translational research, clinical trials, and CDx development across multiple therapeutic areas. Established in 2018, Aignostics is a spin-off from Charité Berlin, one of the world’s largest and most esteemed university hospitals. Aignostics is funded by leading VC investors and has operations in Berlin and New York.
Company Details
- Employees
- 138
- Founded
- -
- Address
- Alt-Moabit 73, Berlin,berlin 10555,germany
- in****@****ics.com
- Industry
- Software Development
- NAICS
-
Software Publishers
- Website
- aignostics.com
- Keywords
- artificial intelligence, pathology, digital pathology, oncology, immuno-oncology, auto immune disease, neurodegenerative disease, improving medicine, companion diagnostics, precision medicine, solutions, R&D, computational pathology, predictive, deep learning, software engineering, translational research, target identification, healthcare, biomarkers.
- HQ
- Berlin, Berlin
Aignostics Questions
Aignostics's website is aignostics.com
Aignostics's LinkedIn profile is https://de.linkedin.com/company/aignostics
Aignostics has
138 employees.
View email and phone details for 138
employees at Aignostics.
Aignostics's industry is
Software Development
Aignostics's top competitors are
Aedifion,
Glassflow,
Briink,
Mindpeak Gmbh,
Aignosis,
Ada Health,
Vara,
Blacklane,
Dunia,
Spread Ai.
Aignostics's support email address is info@aignostics.com
Aignostics's categories are Software Development
Aignostics's founding year is 2018
